Perioperative and Oncological Outcomes of Uniportal Versus Three-Port Thoracoscopic Segmentectomy for Lung Cancer: a Propensity Score Matching Analysis.
Jian Zhou,Quan Zheng,Qiang Pu,Jiandong Mei,Lin Ma,Feng Lin,Chengwu Liu,Chenglin Guo,Hu Liao,Zheng Liu,Yunke Zhu,Guowei Che,Yun Wang,Yidan Lin,Yingli Kou,Yong Yuan,Yang Hu,Zhu Wu,Lunxu Liu
DOI: https://doi.org/10.21037/tlcr-22-635
2023-01-01
Translational Lung Cancer Research
Abstract:Background:With an increasing amount of small nodules being detected, segmentectomy has recently received a great deal of attention. We have previously reported the feasibility and safety of uniportal segmentectomy. This study aims to further compare the perioperative and oncological outcomes of uniportal and three-port thoracoscopic segmentectomy in lung cancer patients.Methods:Patients undergoing thoracoscopic segmentectomy for lung cancer from January 2014 to March 2021 were enrolled. Clinical data were collected from the Western China Lung Cancer Database, a prospectively maintained database at the Department of Thoracic Surgery, West China Hospital. Propensity score matching (PSM) was used to reduce the heterogeneity in baseline characteristics. Perioperative outcomes, 1-, 3-, and 5-year overall survival (OS), and progression-free survival (PFS) were compared.Results:Of the 10,063 lung cancer patients who underwent thoracoscopic lung resection, 2,630 patients receiving segmentectomy were selected (uniportal: 400; three-port: 2,230). After matching, similar results were found between the 2 groups (uniportal: 400; three-port: 1,200) regarding the number of lymph nodes harvested, the length of postoperative hospital stays, chest tube drainage volume, and postoperative complication rate. The mean follow-up duration was 27 months. Uniportal regimen showed similar 1- (100% vs. 99.9%, P=0.36), 3- (100% vs. 90.4%, P=0.20), 5-year OS (97.7% vs. 99.4%, P=0.78), as well as PFS, with the three-port regimen.Conclusions:Uniportal video-assisted thoracoscopic segmentectomy is proven to be safe and feasible, and the perioperative outcomes and oncological results were similar between the uniportal and three-port regimens.